France· FR:63586968
ISENTRESS 100 mg, comprimé à croquer
A medicinal product containing raltégravir potassique, registered in France by MERCK SHARP & DOHME (PAYS-BAS), on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- RALTÉGRAVIR POTASSIQUE
- Manufacturer
- MERCK SHARP & DOHME (PAYS-BAS)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip133400926992576flacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 60 comprimé(s)EUR 151.83
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Raltégravir potassique in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumIsentress 100 mgMerck Sharp & Dohme
- CzechiaISENTRESSMerck Sharp & Dohme B.V., Haarlem
- SpainISENTRESS 100 MG COMPRIMIDOS MASTICABLESMerck Sharp & Dohme B.V.
- FinlandISENTRESSMerck Sharp & Dohme B.V.
- United KingdomIsentress 100mg chewable tabletsMerck Sharp & Dohme (UK) Ltd
- IrelandIsentress 100 mg Chewable tabletMerck Sharp & Dohme BV
- IcelandIsentressMerck Sharp & Dohme B.V.*
- NetherlandsIsentress 100 mg kauwtablettenMerck Sharp & Dohme B.V.
Authorised across Europe · EMA
The same active substance is authorised in 22 EEA countries. Names it is sold under:
- Bulgaria · Raltegravir Viatris, Ралтегравир Зентива
- Cyprus · Raltegravir Viatris
- Germany · Raltegravir Axiromed, Raltegravir Beta
- Denmark · Raltegravir Viatris, Raltegravir Zentiva
- Estonia · Raltegravir Viatris, Raltegravir Zentiva
- Spain · Raltegravir Dr. Reddys, Raltegravir Zentiva
- Finland · Raltegravir Viatris, Raltegravir Zentiva
- United Kingdom (Northern Ireland) · Raltegravir Amarox, Raltegravir Dr. Reddy's Laboratories (Uk)
- Greece · Ralpecin, Raltegravir Viatris
- Croatia · Raltegravir Viatris
- Iceland · Isentress, Raltegravir Zentiva
- Italy · Raltegravir Dr. Reddy’s, Raltegravir Mylan
- Liechtenstein · Isentress
- Lithuania · Raltegravir Zentiva
- Latvia · Raltegravir Viatris, Raltegravir Zentiva
- Malta · Raltegravir Viatris
- Netherlands · Raltegravir Rockmed Pharma, Raltegravir Viatris
- Norway · Isentress, Raltegravir Viatris
- Poland · Raltegravir Viatris
- Portugal · Raltegravir Mylan, Raltegravir Zentiva
- Romania · Raltegravir Viatris, Raltegravir Zentiva
- Sweden · Raltegravir Zentiva
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f3792653-b22e-4654-bcd7-6c3f6e47f613 GET /v1/drugs/f3792653-b22e-4654-bcd7-6c3f6e47f613?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "63586968",
"date_amm": "2013-02-25",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/07/436",
"substance": "RALTÉGRAVIR POTASSIQUE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé à croquer",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about raltégravir potassique.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.